PARNAX LAB LTD.

Company Profile

PARNAX LAB LTD. had its IPO on under the ticker symbol PARNAXLAB.

The company operates in the sector and industry. PARNAX LAB LTD. has a staff strength of 0 employees.

Stock update

Shares of PARNAX LAB LTD. opened at ₹97.8 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹89 - ₹97.8, and closed at ₹95.55.

This is a +2.53% increase from the previous day's closing price.

A total volume of 40,989 shares were traded at the close of the day’s session.

In the last one week, shares of PARNAX LAB LTD. have increased by +14.89%.

PARNAX LAB LTD.'s Key Ratios

PARNAX LAB LTD. has a market cap of ₹596.70 million, indicating a price to book ratio of 1.5426 and a price to sales ratio of 0.4343.

In the last 12-months PARNAX LAB LTD.’s revenue was ₹0 with a gross profit of ₹461.49 million and an EBITDA of ₹0. The EBITDA ratio measures PARNAX LAB LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, PARNAX LAB LTD.’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q4, PARNAX LAB LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

PARNAX LAB LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into PARNAX LAB LTD.’s profitability.

PARNAX LAB LTD. stock is trading at a EV to sales ratio of 0.819 and a EV to EBITDA ratio of 5.7159. Its price to sales ratio in the trailing 12-months stood at 0.4343.

PARNAX LAB LTD. stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹1.43 billion

Total Liabilities

₹645.97 million

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

PARNAX LAB LTD. ended 2024 with ₹1.43 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.43 billion while shareholder equity stood at ₹576.66 million.

PARNAX LAB LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹645.97 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹4.81 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹140.70 million.

PARNAX LAB LTD.’s total current assets stands at ₹637.85 million while long-term investments were ₹0 and short-term investments were ₹15.61 million. Its net receivables were ₹307.97 million compared to accounts payable of ₹137.42 million and inventory worth ₹218.26 million.

In 2024, PARNAX LAB LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, PARNAX LAB LTD. paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹95.55

52-Week High

₹134.6

52-Week Low

₹47.1

Analyst Target Price

₹

PARNAX LAB LTD. stock is currently trading at ₹95.55 per share. It touched a 52-week high of ₹134.6 and a 52-week low of ₹134.6. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹79.65 and 200-day moving average was ₹70.04 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.